Login or Sign Up
15:56 Apr 29
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
15:56 Apr 29
Quality
75/100
High Financial Strength
Valuation
15/100
Expensive Valuation
Technical
32/100
Technically Bearish
Strength
8
Weakness
6
Opportunity
1
Threats
0
16.30K
Market Cap (Cr)
49.95
PE Ratio
10.25
Price to Book Ratio
37.65
RSI
30.29 %
Net Profit Margin
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
